Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
Not Confirmed
Not Confirmed
17-20 March, 2025
Not Confirmed
Not Confirmed
24-26 February, 2025
The Generic Rx SessionThe Generic Rx Session
Not Confirmed
Not Confirmed
24-27 February, 2025
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
Industry Trade Show
Not Confirmed
17-20 March, 2025
Industry Trade Show
Not Confirmed
24-26 February, 2025
The Generic Rx SessionThe Generic Rx Session
Industry Trade Show
Not Confirmed
24-27 February, 2025
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/translational-pharmaceutics-our-flagship-platform-for-drug-development-empowers-our-clients-with-unparalleled-flexibility
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/fda-s-first-generic-approvals-slump-21-in-2024-novartis-top-seller-entresto-cancer-blockbuster-tasigna-lead-2024-patent-cliff
28 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/27/3015292/0/en/AB2-Bio-signs-U-S-option-and-licensing-agreement-with-Nippon-Shinyaku-for-Tadekinig-alfa-for-an-ultra-rare-autoimmune-disease.html
15 Jan 2025
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/regenxbio-and-nippon-shinyaku-announce-exclusive-partnership-to-develop-and-commercialize-rgx-121-and-rgx-111-for-mps-diseases-302350270.html
02 Jan 2025
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2025/01/02/3003570/0/en/Capricor-Therapeutics-Completes-Submission-of-Biologics-License-Application-to-the-U-S-FDA-for-Deramiocel-for-the-Treatment-of-Duchenne-Muscular-Dystrophy.html
13 Nov 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/11/13/2979922/0/en/Nippon-Shinyaku-and-Atsena-Therapeutics-enter-into-an-Exclusive-Strategic-Collaboration-for-ATSN-101-in-the-U-S-and-Japan.html
15 Oct 2024
// PR NEWSWIRE
https://www.prnewswire.com/news-releases/ns-pharmas-galactic53-trial-data-is-published-in-scientific-reports-302273663.html
19 Sep 2024
// James Waldron FIERCE BIOTECH
https://www.fiercebiotech.com/biotech/capricor-sells-europe-rights-dmd-therapy-35m-fda-application-approaches
Excipients
ABOUT THIS PAGE
Nippon Shinyaku is a supplier offers 2 products (APIs, Excipients or Intermediates).
Find a price of Fluoromethane Sulfoanilide Hydrochloride bulk offered by Nippon Shinyaku
Find a price of NS-065/NCNP-01 bulk offered by Nippon Shinyaku